CLONDALKIN GROUP TO ACQUIRE THE PRINTED COMPONENTS BUSINESS OF CATALENT PHARMA SOLUTIONS
Clondalkin Group and Catalent Pharma Solutions today announced that Clondalkin has agreed to acquire the Printed Components business of Catalent. Terms of the transaction were not disclosed, and closing is subject to receipt of regulatory approval.
In addition, at closing Clondalkin and Catalent will enter into a long-term supply agreement which ensures that Catalent will continue to be able to provide customers of its marketleading commercial packaging business with high-quality printed components.
With annual sales in excess of $100 million (€75 million), Printed Components manufactures secondary packaging products for the pharmaceutical and healthcare markets at four production locations in the United States, Puerto Rico and Ireland.
|
For more information contact Ernie Chaplin 508 478 7641 www.kellercrescent.com/newsletter.html |
|---|
|
Happenings
To find out more about Clondalkin Group's recent acquisition, please click here to read the full article. |
|---|
| News Brief
Clondalkin Group is an international producer of high value-added packaging products and services with over 40 production locations in 10 different countries throughout Europe and North America and annual sales in excess of €850 million. The Clondalkin Group pharmaceutical and healthcare businesses operate from 14 accredited production sites in the United States in North Carolina, Indiana, Connecticut, and Puerto Rico as well as in Europe, in Ireland, Spain, the United Kingdom and Poland. For more information, please visit www.clondalkin-group.com |
|---|
